Posted on Leave a comment

US patent for Titan Pharma’s Probuphine to treat opiate addiction

More info…
Titan Pharmaceuticals, Inc.,a biopharmaceutical company with valuable assets in the CNS (central nervous system), announced that the United States Patent and Trademark Office (USPTO) has issued patent number 7,736,665 covering Probuphine for the treatment of opiate addiction.

opiate detox

Leave a Reply

Your email address will not be published.